Chanuka D S Ranmuthu1, Charindu K I Ranmuthu1, Wasim S Khan2,3. 1. University of Cambridge, Cambridge, UK. 2. University of Cambridge, Cambridge, UK. wasimkhan@doctors.org.uk. 3. Department of Trauma and Orthopaedics, Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK. wasimkhan@doctors.org.uk.
Abstract
PURPOSE OF REVIEW: Recent studies have investigated the effect of treatments containing adipose-derived mesenchymal stem cells (ADMSCs) on human osteoarthritis. These have mostly used biologic adjuvants which may influence results. Thus, the purpose of this systematic review is to evaluate the current literature on these treatments when used in isolation. RECENT FINDINGS: Five studies in this review used cultured ADMSCs, while four studies used stromal vascular fraction and three used micro-fragmented adipose tissue to deliver ADMSCs. No studies reported serious treatment-related adverse effects and all reported improvements in clinical measures for at least one dose. This was not necessarily reflected in imaging evaluations nor were improvements always maintained. Current low-level evidence is limited due to variability in study methodology but indicates that treatments containing ADMSCs, when used in isolation, are safe and have the potential to reduce pain and improve function. Randomized controlled trials are now needed.
PURPOSE OF REVIEW: Recent studies have investigated the effect of treatments containing adipose-derived mesenchymal stem cells (ADMSCs) on human osteoarthritis. These have mostly used biologic adjuvants which may influence results. Thus, the purpose of this systematic review is to evaluate the current literature on these treatments when used in isolation. RECENT FINDINGS: Five studies in this review used cultured ADMSCs, while four studies used stromal vascular fraction and three used micro-fragmented adipose tissue to deliver ADMSCs. No studies reported serious treatment-related adverse effects and all reported improvements in clinical measures for at least one dose. This was not necessarily reflected in imaging evaluations nor were improvements always maintained. Current low-level evidence is limited due to variability in study methodology but indicates that treatments containing ADMSCs, when used in isolation, are safe and have the potential to reduce pain and improve function. Randomized controlled trials are now needed.
Authors: J D Harris; R A Siston; R H Brophy; C Lattermann; J L Carey; D C Flanigan Journal: Osteoarthritis Cartilage Date: 2011-02-17 Impact factor: 6.576
Authors: Marita Cross; Emma Smith; Damian Hoy; Sandra Nolte; Ilana Ackerman; Marlene Fransen; Lisa Bridgett; Sean Williams; Francis Guillemin; Catherine L Hill; Laura L Laslett; Graeme Jones; Flavia Cicuttini; Richard Osborne; Theo Vos; Rachelle Buchbinder; Anthony Woolf; Lyn March Journal: Ann Rheum Dis Date: 2014-02-19 Impact factor: 19.103
Authors: Stefan Marlovits; Philip Zeller; Philipp Singer; Christoph Resinger; Vilmos Vécsei Journal: Eur J Radiol Date: 2005-09-26 Impact factor: 3.528
Authors: Kai Mithoefer; Riley J Williams; Russell F Warren; Hollis G Potter; Christopher R Spock; Edward C Jones; Thomas L Wickiewicz; Robert G Marx Journal: J Bone Joint Surg Am Date: 2005-09 Impact factor: 5.284
Authors: Shoukrie I Shoukrie; Sathish Venugopal; Ravneet K Dhanoa; Ramaneshwar Selvaraj; Tharun Y Selvamani; Anam Zahra; Jyothirmai Malla; Ranim K Hamouda; Pousette F Hamid Journal: Cureus Date: 2022-05-08